Dr. Panagakos is the Vice President of Scientific and Clinical Affairs for Geistlich Pharm, North America, which is based in Princeton, N.J. He oversees the clinical science team's activities related to developing clinical studies and strengthening relationships with external stakeholders. Before this role, he worked for more than 12 years at the Colgate-Palmolive Company, where his roles included oral care research and development, scientific affairs and relationship-building with the professional and consumer communities. In his last role at Colgate-Palmolive, Dr. Panagakos served as Global Director of Scientific Affairs in Oral Care Clinical Research.
Dr. Panagakos received his DMD from UMDNJ-New Jersey Dental School and his PhD in Biochemistry and Molecular Biology from UMDNJ-Graduate School of Biomedical Sciences in 1992. In 1999, he received his Masters in Education from Seton Hall University and in 2007 he received his Master’s in Business Administration from Lehigh University.
Dr. Panagakos served for 14 years as a faculty member at New Jersey Dental School. He was active in both the undergraduate and graduate dental teaching programs at NJDS and had an active research program, examining the role of inflammatory proteins on connective tissue biology and function. Dr. Panagakos is the coauthor of more than 70 peer-reviewed scientific research articles and the co-editor of three dental science textbooks.